The Union Budget 2024 has received praise from doctors and the healthcare industry for exempting three crucial cancer drugs from customs duty. This move aims to make life-saving treatments more affordable and accessible to patients. By reducing the cost of these expensive medications, the government is taking a significant step toward easing the financial burden on cancer patients and improving healthcare outcomes. This exemption reflects a positive push towards more patient-centered healthcare policies.
